MERIDIAN BIOSCIENCE, INC. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 60 rows in 2023. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2023-01-31: Reporting owner Williams Felicia; Form 4; Security Stock Option (Right to Buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2023-01-31: Reporting owner Williams Felicia; Form 4; Security Stock Option (Right to Buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2023-01-31: Reporting owner Williams Felicia; Form 4; Security Stock Option (Right to Buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2023-01-31: Reporting owner Williams Felicia; Form 4; Security Stock Option (Right to Buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2023-01-31 | Williams Felicia Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −12,000 0 owned after | $18.85 | 2023-01-31 | |
| 2023-01-31 | Williams Felicia Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −8,740 0 owned after | $17.03 | 2023-01-31 | |
| 2023-01-31 | Williams Felicia Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −17,205 0 owned after | $23.54 | 2023-01-31 | |
| 2023-01-31 | Williams Felicia Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −5,796 0 owned after | $12.64 | 2023-01-31 | |
| 2023-01-31 | Williams Felicia Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −5,656 0 owned after | $13.25 | 2023-01-31 | |
| 2023-01-31 | Sazdanoff Catherine Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −8,500 0 owned after | $15.82 | 2023-01-31 | |
| 2023-01-31 | Sazdanoff Catherine Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −8,500 0 owned after | $15.36 | 2023-01-31 | |
| 2023-01-31 | Sazdanoff Catherine Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −12,000 0 owned after | $21.20 | 2023-01-31 | |
| 2023-01-31 | Sazdanoff Catherine Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −12,000 0 owned after | $17.80 | 2023-01-31 | |
| 2023-01-31 | Sazdanoff Catherine Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −8,740 0 owned after | $17.03 | 2023-01-31 | |
| 2023-01-31 | Sazdanoff Catherine Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −17,205 0 owned after | $23.54 | 2023-01-31 | |
| 2023-01-31 | Sazdanoff Catherine Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −5,796 0 owned after | $12.64 | 2023-01-31 | |
| 2023-01-31 | Sazdanoff Catherine Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −5,656 0 owned after | $13.25 | 2023-01-31 | |
| 2023-01-31 | Rice John McCune Jr. Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −12,000 0 owned after | $17.80 | 2023-01-31 | |
| 2023-01-31 | Rice John McCune Jr. Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −8,740 0 owned after | $17.03 | 2023-01-31 | |
| 2023-01-31 | Rice John McCune Jr. Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −5,796 0 owned after | $12.64 | 2023-01-31 | |
| 2023-01-31 | Rice John McCune Jr. Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −5,656 0 owned after | $13.25 | 2023-01-31 | |
| 2023-01-31 | McIlwraith John Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −8,500 0 owned after | $15.82 | 2023-01-31 | |
| 2023-01-31 | McIlwraith John Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −8,500 0 owned after | $15.36 | 2023-01-31 | |
| 2023-01-31 | McIlwraith John Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −10,000 0 owned after | $21.20 | 2023-01-31 | |
| 2023-01-31 | McIlwraith John Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −12,000 0 owned after | $17.80 | 2023-01-31 | |
| 2023-01-31 | McIlwraith John Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −8,740 0 owned after | $17.03 | 2023-01-31 | |
| 2023-01-31 | McIlwraith John Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −17,205 0 owned after | $23.54 | 2023-01-31 | |
| 2023-01-31 | McIlwraith John Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −5,796 0 owned after | $12.64 | 2023-01-31 | |
| 2023-01-31 | McIlwraith John Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −5,656 0 owned after | $13.25 | 2023-01-31 | |
| 2023-01-31 | Ellingwood Dwight E Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −8,500 0 owned after | $13.20 | 2023-01-31 | |
| 2023-01-31 | Ellingwood Dwight E Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −5,500 0 owned after | $16.66 | 2023-01-31 | |
| 2023-01-31 | Ellingwood Dwight E Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −8,500 0 owned after | $15.36 | 2023-01-31 | |
| 2023-01-31 | Ellingwood Dwight E Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −11,000 0 owned after | $21.20 | 2023-01-31 | |
| 2023-01-31 | Ellingwood Dwight E Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −12,000 0 owned after | $17.80 | 2023-01-31 | |
| 2023-01-31 | Ellingwood Dwight E Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −8,740 0 owned after | $17.03 | 2023-01-31 | |
| 2023-01-31 | Ellingwood Dwight E Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −17,205 0 owned after | $23.54 | 2023-01-31 | |
| 2023-01-31 | Ellingwood Dwight E Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −5,796 0 owned after | $12.64 | 2023-01-31 | |
| 2023-01-31 | Ellingwood Dwight E Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −5,656 0 owned after | $13.25 | 2023-01-31 | |
| 2023-01-31 | Bihl Anthony P III Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −4,595 0 owned after | $10.50 | 2023-01-31 | |
| 2023-01-31 | Bihl Anthony P III Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −5,796 0 owned after | $12.64 | 2023-01-31 | |
| 2023-01-31 | Bihl Anthony P III Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −5,656 0 owned after | $13.25 | 2023-01-31 | |
| 2023-01-31 | Anderson James M. Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −8,500 0 owned after | $8.17 | 2023-01-31 | |
| 2023-01-31 | Anderson James M. Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −8,500 0 owned after | $16.66 | 2023-01-31 | |
| 2023-01-31 | Anderson James M. Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −8,500 0 owned after | $15.36 | 2023-01-31 | |
| 2023-01-31 | Anderson James M. Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −12,000 0 owned after | $21.20 | 2023-01-31 | |
| 2023-01-31 | Anderson James M. Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −12,000 0 owned after | $17.80 | 2023-01-31 | |
| 2023-01-31 | Anderson James M. Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −8,740 0 owned after | $17.03 | 2023-01-31 | |
| 2023-01-31 | Anderson James M. Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −17,205 0 owned after | $23.54 | 2023-01-31 | |
| 2023-01-31 | Anderson James M. Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −5,796 0 owned after | $12.64 | 2023-01-31 | |
| 2023-01-31 | Anderson James M. Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −5,656 0 owned after | $13.25 | 2023-01-31 | |
| 2023-01-31 | Kenny John P. Director, Officer (Chief Executive Officer), 10% Owner | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −66,039 0 owned after | $23.90 | 2023-01-31 | |
| 2023-01-31 | Kenny John P. Director, Officer (Chief Executive Officer), 10% Owner | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −83,535 0 owned after | $15.52 | 2023-01-31 | |
| 2023-01-31 | Kenny John P. Director, Officer (Chief Executive Officer), 10% Owner | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −82,940 0 owned after | $15.12 | 2023-01-31 | |
| 2023-01-31 | Kitzmiller Andrew S. Officer (Executive Vice President & CFO) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −5,000 0 owned after | $9.26 | 2023-01-31 | |
| 2023-01-31 | WELTZIEN LOURDES Officer (Executive VP, Life Science) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −10,000 0 owned after | $14.34 | 2023-01-31 | |
| 2023-01-31 | WELTZIEN LOURDES Officer (Executive VP, Life Science) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −2,500 0 owned after | $19.70 | 2023-01-31 | |
| 2023-01-31 | WELTZIEN LOURDES Officer (Executive VP, Life Science) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −12,107 0 owned after | $15.52 | 2023-01-31 | |
| 2023-01-31 | WELTZIEN LOURDES Officer (Executive VP, Life Science) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −11,669 0 owned after | $15.12 | 2023-01-31 | |
| 2023-01-31 | Serafini-Lamanna Tony Officer (Executive VP-Diagnostics) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −10,000 0 owned after | $19.40 | 2023-01-31 | |
| 2023-01-31 | Serafini-Lamanna Tony Officer (Executive VP-Diagnostics) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −4,000 0 owned after | $27.03 | 2023-01-31 | |
| 2023-01-31 | Serafini-Lamanna Tony Officer (Executive VP-Diagnostics) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −12,107 0 owned after | $15.52 | 2023-01-31 | |
| 2023-01-31 | Serafini-Lamanna Tony Officer (Executive VP-Diagnostics) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −11,669 0 owned after | $15.12 | 2023-01-31 | |
| 2023-01-31 | Smith Julie Diana Officer (Sr VP, Controller, PAO) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −2,000 0 owned after | $27.03 | 2023-01-31 | |
| 2023-01-06 | Anderson James M. Director | 4 | Stock Options (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −8,500 0 owned after | $20.38 exercise price | 2023-01-09 |